Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Further clarity needed & size of mkt.

<< Previous

Bullboard Posts

Next >>

Comment by Mannequinon Dec 12, 2024 9:11am

82 Views

Post# 36358520

RE:RE:RE:RE:RE:RE:RE:Further clarity needed & size of mkt.

Most of us were too foolish to believe the authenticity of their words and timing of actions. Those failings by Dawn and blowing the expenses creating the marathon fiasco (above all else) are why these new press releases have done nothing at all. No one trusts these guys. The vast majority of the board must be changed. There needs to be a clean sweep so a new team is at the helm.

<< Previous

Bullboard Posts

Next >>

Invest wiser with BMO's InvestorLine Platform features